The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

In 2025 it seemed the only certainty for biotech was more uncertainty. Biotech leaders conducted business as usual against the background of ongoing funding challenges and ever-increasing drug ...

Organoids, assembloids, and organ-on-a-chip technologies represent transformative advances in the fields of drug discovery, precision medicine, and ...

The biotech market is showing signs of recovery, with increased deal-making activity expected to continue into 2026. Artificial intelligence (AI) and data analytics are becoming more important for ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

President Donald Trump said Saturday that the United States and Latin American countries are banding together to combat ...